Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,179
archived clinical trials in
Anxiety

Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Columbia, SC
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Carolina Clinical Research Services
mi
from
Columbia, SC
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Sioux Falls, SD
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Avera Research Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Memphis, TN
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Austin, TX
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
FutureSearch Trials
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Dallas, TX
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Houston, TX
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Houston, TX
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Medlabs Research Of Houston, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Houston, TX
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Midlothian, VA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Dominion Clinical Research
mi
from
Midlothian, VA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
mi
from
Middleton, WI
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Dean Foundation For Health Research & Education
mi
from
Middleton, WI
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
mi
from
Washington,
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
mi
from
Bethesda, MD
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
mi
from
Detroit, MI
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Henry Ford Health Systems
mi
from
Detroit, MI
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
mi
from
New York, NY
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
mi
from
New York, NY
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
mi
from
Every Cedex,
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Genethon
mi
from
Every Cedex,
Click here to add this to my saved trials
Psychotherapy for Depressed or Anxious Adolescents With Cancer
Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer
Status: Enrolling
Updated:  10/5/2015
mi
from
New York, NY
Psychotherapy for Depressed or Anxious Adolescents With Cancer
Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer
Status: Enrolling
Updated: 10/5/2015
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Status: Enrolling
Updated:  10/6/2015
mi
from
Bethesda, MD
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
Status: Enrolling
Updated: 10/6/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
Status: Enrolling
Updated:  10/8/2015
mi
from
Columbus, OH
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence
Status: Enrolling
Updated: 10/8/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Mobile, AL
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Phoenix, AZ
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Greater Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Scottsdale, AZ
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Denver, CO
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Honolulu, HI
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Decatur, IL
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Wichita, KA
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Kalamazoo, MI
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Saint Louis Park, MN
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Hackensack, NJ
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Northern New Jersey
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Manhasset, NY
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Syracuse, NY
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Winston-Salem, NC
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Columbus, OH
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Dayton, OH
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Seattle, WA
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Tacoma, WA
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated:  10/13/2015
mi
from
Marshfield, WI
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Control of Vasomotor Symptoms in Women Treated for Breast Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Marshfield Medical Research and Education Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Medical Use of Song In Critical Care (MUSIC)
Medical Use of Song In Critical Care (MUSIC)
Status: Enrolling
Updated:  10/20/2015
mi
from
Boston, MA
Medical Use of Song In Critical Care (MUSIC)
Medical Use of Song In Critical Care (MUSIC)
Status: Enrolling
Updated: 10/20/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety Disorder
Cognitive and Interpersonal Therapies for Generalized Anxiety
Status: Enrolling
Updated:  11/3/2015
mi
from
University Park, PA
Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety Disorder
Cognitive and Interpersonal Therapies for Generalized Anxiety
Status: Enrolling
Updated: 11/3/2015
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
Self-Defense Training in Women With Trauma
A Pilot Study of Self-Defense Training in Women With Trauma
Status: Enrolling
Updated:  11/18/2015
mi
from
Stanford, CA
Self-Defense Training in Women With Trauma
A Pilot Study of Self-Defense Training in Women With Trauma
Status: Enrolling
Updated: 11/18/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
Status: Enrolling
Updated:  11/24/2015
mi
from
Aurora, CO
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
Status: Enrolling
Updated: 11/24/2015
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Pediatric Laser Acupuncture and Renal Biopsy
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated:  11/30/2015
mi
from
San Francisco, CA
Pediatric Laser Acupuncture and Renal Biopsy
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated: 11/30/2015
University of California San Francisco Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pediatric Laser Acupuncture and Renal Biopsy
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated:  11/30/2015
mi
from
San Francisco, CA
Pediatric Laser Acupuncture and Renal Biopsy
Efficacy of Laser Therapy as an Adjuvant Treatment During Kidney Biopsies to Decrease Anxiety and Pain.
Status: Enrolling
Updated: 11/30/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Status: Enrolling
Updated:  11/30/2015
mi
from
La Jolla, CA
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes
Status: Enrolling
Updated: 11/30/2015
UCSD Psychiatry Clinical Research
mi
from
La Jolla, CA
Click here to add this to my saved trials
Lavender Aromatherapy for Anxiety During Urodynamics
The Use of Lavender Aromatherapy to Decrease Women's Anxiety and Perception of Pain During Multi-channel Urodynamics Procedure
Status: Enrolling
Updated:  11/30/2015
mi
from
Los Angeles, CA
Lavender Aromatherapy for Anxiety During Urodynamics
The Use of Lavender Aromatherapy to Decrease Women's Anxiety and Perception of Pain During Multi-channel Urodynamics Procedure
Status: Enrolling
Updated: 11/30/2015
Los Angeles Count + USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Status: Enrolling
Updated:  11/30/2015
mi
from
Austin, TX
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
Status: Enrolling
Updated: 11/30/2015
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/2/2015
mi
from
Hartford, CT
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/2/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Brief Behavioral Treatment for Anxiety in Young Children
A Brief Behavioral Treatment for Anxiety in Young Children
Status: Enrolling
Updated:  12/2/2015
mi
from
St. Petersburg, FL
Brief Behavioral Treatment for Anxiety in Young Children
A Brief Behavioral Treatment for Anxiety in Young Children
Status: Enrolling
Updated: 12/2/2015
Rothman Center for Pediatric Neuropsychiatry - University of South Florida
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status: Enrolling
Updated:  12/2/2015
mi
from
New York City, NY
Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
A Feasibility Study for a Phase 3, Randomized, Four-Week, Double-Blind, Placebo-Controlled, Crossover Trial of the Efficacy and Safety of PH94B Nasal Spray in the Acute Treatment of Social Anxiety Disorder (SAD)
Status: Enrolling
Updated: 12/2/2015
Medical Research Network
mi
from
New York City, NY
Click here to add this to my saved trials
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
A Retrospective Analysis of Outcomes in Outpatients With Major Depressive Disorder (MDD) in a Staff Model HMO: Pharmacogenetic Algorithm for Psychotropic Pharmacotherapeutic Applications
Status: Enrolling
Updated:  12/4/2015
mi
from
Chicago, IL
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
A Retrospective Analysis of Outcomes in Outpatients With Major Depressive Disorder (MDD) in a Staff Model HMO: Pharmacogenetic Algorithm for Psychotropic Pharmacotherapeutic Applications
Status: Enrolling
Updated: 12/4/2015
Union Health Services
mi
from
Chicago, IL
Click here to add this to my saved trials